1. Akao T., 2002. Evolution of salicin as an antipyretic prodrug that does not cause gastric injury. Planta Medica, 68, 714-8.
2. Bruneton J., 2002. Phytothérapie : les données de l’évaluation. Tec & Doc ; 99-100.
3. Chrubasik S., et al., 2000. Treatment of low back pain exacerbations with willow bark extract : a randomised double blind study. Am. J. Med., 109(1) : 9-14.
4. Chrubasik S., et al., 2001. Potential economic impact of using a proprietary willow bark extract in outpatient treatment of low back pain : an open non-randomized study. Phytomedicine, 8(4) : 241-51.
5. Chrubasik S., et al., 2001. Treatment of low back pain with a herbal or synthetic antirheumatic : a randomized controlled study. Willow bark extract for low back pain. Rheumatology, 40 : 1388-93.
6. Higgs G.A., et al., 1987. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc. Natl. Acad. Sci., 84(5) : 1417-20.
7. Jellin J.M., 1999. Pharmacist’s Letter / Prescriber’s Letter Natural Medicines Comprehensive Database. Stockton, CA : Therapeutic Research Faculty.
8. Krivoy N., et al., 2001. Effect of salicis cortex extract on human platelet aggregation. Planta Med., 67(3) : 209-12.
9. Lambert J.P., 1999. Des interactions “naturelles”. Québec Pharmacie, 46 : 789-97.
10. Raynaud J., 2005. Prescription et conseil en phytothérapie.Ed. Tec. & Doc., 196-8.
11. Schmid B., et al., 2001. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis : randomized placebo-controlled, double blind clinical trial. Phytother. Res., 15(4) : 344-50.
12. Wichtl M., et al., 2003. Plantes thérapeutiques : tradition, pratique officinale, science et thérapeutique. Ed. Tec. & Doc., 490-3.
13. Zaugg S.E., et al., 1997. Capillary electrophoretic analysis of salicin in Salix spp. Journal of Chromatography A., 781 : 487-90.